Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis

Clinical and Experimental Allergy

Volumn 34, Issue 4, 2004, Pages 650-653

  Lee, D K C ^a   Gardiner, M ^a   Haggart, K ^a   Fujihara, S ^a   Lipworth, B J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Adenosine monophosphate; Desloratadine; Fexofenadine; H1 antihistamine; Levocetirizine; Nasal challenge; Peak nasal inspiratory flow; Perennial allergic rhinitis

Indexed keywords

ADENOSINE PHOSPHATE; BUDESONIDE; CETIRIZINE; DESLORATADINE; FEXOFENADINE; FLUTICASONE; LEVOCETIRIZINE; LORATADINE; MOMETASONE FUROATE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INSPIRATORY CAPACITY; MALE; PERENNIAL RHINITIS; PRICK TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADENOSINE MONOPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; ANTI-ALLERGIC AGENTS; CETIRIZINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; LORATADINE; MALE; MIDDLE AGED; NASAL PROVOCATION TESTS; PIPERAZINES; RHINITIS, ALLERGIC, PERENNIAL; TERFENADINE; TREATMENT OUTCOME;

EID: 2042482053     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.1904.x     Document Type: Article

References (24)

1. Anthes JC, Richard C, West RE et al. Functional characterization of desloratadine and other antihistamines in human histamine H1 receptors. Allergy 2000; 55:277.
2. Geha RS, Meltzer EO. Desloratadine: a new, nonsedating, oral antihistamine. J Allergy Clin Immunol 2001; 107:751-62.
3. Wilson AM, Sims EJ, Orr LC, Robb F, Lipworth BJ. An evaluation of short-term corticosteroid response in perennial allergic rhinitis using histamine and adenosine monophosphate nasal challenge. Br J Clin Pharmacol 2003; 55:354-9.
4. Lee DK, Gray RD, Lipworth BJ. Adenosine monophosphate bronchial provocation and the actions of asthma therapy. Clin Exp Allergy 2003; 33:287-94.
5. Wilson AM, Sims EJ, Robb F, Cockburn W, Lipworth BJ. Peak inspiratory flow rate is more sensitive than acoustic rhinometry or rhinomanometry in detecting corticosteroid response with nasal histamine challenge. Rhinology 2003; 41:16-20.
6. Lee DK, Carstairs IJ, Haggart K, Jackson CM, Currie GP, Lipworth BJ. Butterbur, a herbal remedy, attenuates adenosine monophosphate induced nasal responsiveness in seasonal allergic rhinitis. Clin Exp Allergy 2003; 33:882-6.
7. Bachert C, De Shryver L, Holappels G, van Cauwenberge P. Effects of desloratadine on human monocyte activity in vitro. Allergy 2002; 57 (Suppl. 73):145.
8. Biller H, Kunze S, Luttmann W, Virchow JC. Effects of desloratadine on Th2-cytokine secretion of peripheral blood leukocytes from patients with allergic rhinitis, patients with allergic asthma and healthy controls. Allergy 2002; 57 (Suppl. 73):146.
9. Marone G, Gentile M, Petraroli A, De Rosa N, Triggiani M. Histamine-induced activation of human lung macrophages. Int Arch Allergy Immunol 2001; 124:249-52.
10. Triggiani M. Gentile M, Secondo A et al. Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors. J Immunol 2001; 166:4083-91.
11. Paolieri F, Battifora M, Riccio AM et al. Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines. Ann Allergy Asthma Immunol 1998; 81:601-7.
12. Abdelaziz MM, Devalia JL, Khair OA, Bayram H, Prior AJ, Davies RJ. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1998; 101:410-20.
13. Hoda U, Lau LCK, Leir SH, Howarth PH. Influence of fexofenadine on tumour necrosis factor alpha stimulated H292 epithelial cell activation in vitro. Allergy 2002; 57 (Suppl. 73):146.
14. Thomson L, Blaylock MG, Sexton DW, Campbell A, Walsh GM. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clin Exp Allergy 2002; 32:1187-92.
15. Arnold R, Konig B, Campbell A, Freytag CC, Konig W. Levocetirizine modulates inflammatory responses of human neutrophils in the presence of the respiratory syncytial virus. Allergy 2002; 57 (Suppl. 73):146.
16. Ying S, Meng Q. The effect of levocetirizine on histamine and cytokine induced up regulation of eotaxin by endothelial cells. Allergy 2002; 57 (Suppl. 73):145.
17. Wilson AM, Haggart K, Sims EJ, Lipworth BJ. Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis. Clin Exp Allergy 2002; 32:1504-9.
18. Prenner BM, Capano D, Harris AG. Efficacy and tolerability of loratadine vs. fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders. Clin Ther 2000; 22:760-9.
19. van Cauwenberge P, Juniper EF. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clin Exp Allergy 2000; 30:891-9.
20. Lopez GA, Paz MD, Orea SM et al. Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis. Rev Alerg Mex 2001; 48:168-72.
21. Horak F, Stubner P, Zieglmayer R et al. Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis. Int Arch Allergy Immunol 2001; 125:73-9.
22. Van Ganse E, Kaufman L, Derde MP, Yernault JC, Delaunois L, Vincken W. Effects of antihistamines in adult asthma: a meta-analysis of clinical trials. Eur Respir J 1997; 10:2216-24.
23. Lee DK, Jackson CM, Haggart K, Lipworth BJ. Chronic dosing effects of mediator antagonists in inhaled corticosteroid treated atopic asthmatic patients. Chest 2004, (in press).
24. 1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis. Br J Clin Pharmacol 2004, (in press).